Novavax (NVAX) Enterprise Value (2010 - 2026)
Novavax's Enterprise Value was $833.16 million in Q2 2026, up 103.6% from $409.23 million a year earlier and up 52.0% from the prior quarter.
Powered by 
Analysis
Novavax (NVAX) Enterprise Value (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Novavax's Enterprise Value was -$1.46 billion through Jun 30, 2026; for FY2025, it came in at $357.43 million, down 2.5% from FY2024.
- Enterprise Value shows a five-year compound annual growth rate of -42.5% (FY2020 to FY2025).
- In earlier years, Enterprise Value was $366.67 million in FY2024, -$84.82 million in FY2023, -$452.39 million in FY2022 and $9.34 billion in FY2021 (+63.6%).
- The Q2 2026 figure marks the highest quarterly Enterprise Value since Q3 2024.
- Compared with a year earlier, Enterprise Value was higher in four of the last seven quarters, with growth averaging 82.1%.
- The best year-over-year quarter for Enterprise Value over five years was Q3 2024 (growth of 433.9%); the worst was Q3 2022 (a decline of 98.9%).
- Per Business Quant data, NVAX's Enterprise Value in the three quarters before Q2 2026 was $548 million (Q1 2026), $357.43 million (Q4 2025) and $645.69 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Novavax | 1.78 Bn | -1.23 Bn | 42.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 833.16 Mn |
| Mar 31, 2026 | 548.00 Mn |
| Dec 31, 2025 | 357.43 Mn |
| Sep 30, 2025 | 645.69 Mn |
| Jun 30, 2025 | 409.23 Mn |
| Mar 31, 2025 | 306.67 Mn |
| Dec 31, 2024 | 366.67 Mn |
| Sep 30, 2024 | 1.11 Bn |
| Jun 30, 2024 | 974.59 Mn |
| Mar 31, 2024 | 190.38 Mn |
| Dec 31, 2023 | -84.82 Mn |
| Sep 30, 2023 | 208.50 Mn |
| Jun 30, 2023 | 194.80 Mn |
| Mar 31, 2023 | -26.95 Mn |
| Dec 31, 2022 | -452.39 Mn |
| Sep 30, 2022 | 147.70 Mn |
| Jun 30, 2022 | 2.64 Bn |
| Mar 31, 2022 | 4.18 Bn |
| Dec 31, 2021 | 9.34 Bn |
| Sep 30, 2021 | 13.70 Bn |
API Access
Novavax Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=NVAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "NVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=NVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();